Monopolymer multifunctional sequenced cast polyurethane matrix and production thereof
The invention relates to a monopolymer multifunctional sequenced cast polyurethane matrix produced simply and efficiently, by sequentially pouring various isocyanate/polyol complex phase solutions successively into a mold with alternating solidification of said phase solutions according to a defined order and respecting the polymerization stage (after the pot life and before the demolding time) of the sequence preceding the one being cast, so as to end with the casting of the last phase solution that will go up to the demolding time thereof and thereby finish the polymerization of the whole of the matrix. It is loaded, in its “reservoir” sequences, with naturally originating or synthesized transdermally penetrating or volatile active substances. They are medicating and therapeutic, cosmetic, phytosanitary or wellness substances, repellents, attractants, pheromones, biocides, perfumes or deodorants. At least two active substances can be loaded into the same matrix in order to act unidirectionally or in opposite directions. Said matrix is used to form different devices that adhere to the skin or any other surface, in order to deliver at least one substance in a controlled manner. Said devices are patches, patches with a plurality of active substances, replaceable plasters stuck to a textile support, active heel pads and ball pads for shoes, pheromone cards for controlling insects, self-adhesive insecticide attractant cards, or other devices equivalent in terms of structure and function.
1. A sequenced cast matrix consisting essentially of polyurethane structured in successive sequences of polyurethane having a support or support-barrier sequence, a reservoir sequence operable for controlled release of a volatile or transdermally penetrating active substance contained therein, and an adhesive sequence, structured according to a profile wherein the polyurethane matrix is made up of said sequences copolymerised at their contact interfaces which induces structural continuity of the polyurethane matrix,
wherein the sequences are formed of liquid phase solutions obtained by mixing a liquid polyol complex with a liquid isocyanate,
wherein the functionality of each sequence is determined both by the composition of the polyol complex and the stoichiometry of the phase solution used for its making; and
wherein said polyurethane matrix is loaded in the reservoir sequences with a volatile or transdermally penetrating active substance of a natural or synthetic origin.
2. The polyurethane matrix according to claim 1 , wherein the polyurethane matrix includes copolymerised functional sequences according to the following profiles:
A. Support/Reservoir/Adhesive;
B. Reservoir 1/Support-Barrier/Reservoir 2-Adhesive;
C. Support/Reservoir-Adhesive;
D. Reservoir/Support-Barrier/Adhesive;
E. Support/Reservoir 1/Reservoir 2/Adhesive;
F. Support/Reservoir 1/Reservoir 2-Adhesive.
3. The polyurethane matrix according to claim 1 , wherein the polyurethane matrix has a thickness which evolves from a film of 10 to 100 micrometers to a polymer block with a thickness of several centimeters in which each sequence can have a different thickness.
4. The polyurethane matrix according to claim 1 , wherein the thickness of the reservoir sequence varies.
5. The polyurethane matrix according to claim 1 , wherein the polyurethane matrix is loaded in the reservoir sequences with medicinal and therapeutic substances, cosmetic substances, well-being substances, phytosanitary substances, repellents, attractants, pheromones, biocides, perfumes or deodorants.
6. The polyurethane matrix according to claim 1 , wherein several volatile or transdermally penetrating active substances belonging to atmospheric and transdermal activities, are loaded in different reservoir sequences.
7. The polyurethane matrix according to claim 1 , wherein several volatile or transdermally penetrating active substances belonging to the same field of activity are loaded in different reservoir sequences.
8. The polyurethane matrix according to claim 1 , wherein the polyurethane matrix is in the form of a device selected from the group consisting of a patch, a changeable plaster stuck to a textile support, an active heelpiece or an active pad for shoes, a plate with a pheromone to control insects, and an insecticide attracting self-adhesive plate.
9. The polyurethane matrix according to claim 8 , wherein the device adheres to the skin or any other surface, while delivering one or more volatile or transdermally penetrating active substances in a controlled manner.
10. A sequenced cast matrix consisting essentially of successive sequences of polyurethane;
A. wherein each of said successive sequences is prepared as a combination of one or more of—
a support sequence or a support-barrier sequence,
a reservoir sequence operable for controlled release of a volatile or transdermally penetrating active substance contained therein, and
an adhesive sequence,
wherein said successive sequences are structured according to a profile;
B. wherein each sequence is copolymerised at its contact interface with the contact interface of the sequence placed adjacent thereto, which induces structural continuity of the polyurethane matrix;
C. wherein each sequence is formed of a liquid phase solution obtained by mixing a liquid polyol complex with a liquid isocyanate;
D. wherein the functionality of each sequence is determined both by the composition of the polyol complex and the stoichiometry of the liquid phase solution used for its making; and
E. wherein said polyurethane matrix is loaded in the reservoir sequences with a volatile or transdermally penetrating active substance of a natural or synthetic origin.
11. A sequenced cast matrix consisting of polyurethane structured in successive sequences of polyurethane having a support or support-barrier sequence, a reservoir sequence operable for controlled release of a volatile or transdermally penetrating active substance contained therein, and an adhesive sequence, structured according to a profile wherein the polyurethane matrix is made up of said sequences copolymerised at their contact interfaces which induces structural continuity of the polyurethane matrix,
wherein the sequences are formed of liquid phase solutions obtained by mixing a liquid polyol complex with a liquid isocyanate,
wherein the functionality of each sequence is determined both by the composition of the polyol complex and the stoichiometry of the phase solution used for its making; and
wherein said polyurethane matrix is loaded in the reservoir sequences with a volatile or transdermally penetrating active substance of a natural or synthetic origin.